Registration Dossier

Diss Factsheets

Administrative data

Description of key information

A reliable LLNA study (OECD 429) showed no skin sensitisation of CN-Nitcal.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
21 April 2010 to 03 May 2010
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.2600 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)
Species:
mouse
Strain:
CBA
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan, Belton, Leics, England
- Age at study initiation: Animals used within the study were at least 6 weeks old
- Weight at study initiation: body weights were approx 20 g
- Housing: labeled cages with perforated floors (Ebeco, Germany, dimensions 67 x 62 x 55 cm) and shelters (Ebeco, Germany, dimensions 40 x 32 x 23 cm).
- Diet (e.g. ad libitum): Pelleted diet for rabbits (Global Diet 2030 from Harlan Teklad®, Mucedola, Milanese, Italy) approximately 100 grams per day. Hay (TecniLab-BMI BV, Someren, The Netherlands) was provided at least three times a week.
- Water (e.g. ad libitum): Free access to tap water.
- Acclimatization period: at least 5 days before start of treatment under laboratory conditions.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.5 ¿ 20.6ºC
- Humidity (%): 36 - 65%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hours artificial fluorescent light and 12 hours darkness per day

IN LIFE DATES: From: 21 April 2010 To: 03 May 2010
Vehicle:
other: Ethanol/water (7:3 v/v)
Concentration:
1 0% (Ethanol/water 7:3)
2 10%
3 25%
4 50%
No. of animals per dose:
5
Details on study design:
PRELIMINARY IRRITATION STUDY
A preliminary irritation study was conducted in order to select the highest test substance concentration to be used in the main study. In principle, this concentration should be well tolerated systemically by the animals and may give moderate irritation (maximally grade 2; see section 6.6) at the highest concentration.

Two test substance concentrations were tested; a 25% and 50% concentration. The highest concentration was the maximum concentration as required in the test guidelines (undiluted for liquids, 50% for solids).
The test system, procedures and techniques were identical to those used during Days 1 to 3 of the main study unless otherwise specified. Two young adult animals were selected (8-14 weeks old; Janvier, Le Genest-Saint-Isle, France). Each animal was treated with one concentration on three consecutive days. Approximately 3-4 hours after the last exposure, the irritation of the ears was assessed. Bodyweights were determined on Day 3. The animals were sacrificed after the final observation and no necropsy was performed.

MAIN STUDY
ANIMAL ASSIGMENT AND TREATMENT
-Name of the test method: Local Lymph Node Assay
-Criteria used to consider a positive response: DPM values are presented for each animal and for each dose group. A Stimulation Index (SI) is calculated for each group. The SI is the ratio of the DPM/group compared to DPM/vehicle control group.
If the results indicate a SI ¿ 3, the test substance may be regarded as a skin sensitizer, based on the test guideline and recommendations done by ICCVAM.The results were evaluated according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations (2007) and the Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labeling and packaging of substances and mixtures.Consideration was given to the EC3 value (the estimated test substance concentration that will give a SI =3).

TREATMENT PREPARATION AND ADMINISTRATION:
The test substance and positive control substance formulations (w/w) were prepared within 4 hours prior to each treatment. No adjustment was made for specific gravity of the vehicle. Homogeneity was obtained to visually acceptable levels.

Three groups of five animals were treated with one test substance concentration per group. The highest test substance concentration was selected from the preliminary irritation study.
One group of five animals was treated with vehicle and another group of five animals was treated with the positive control substance.

Induction - Days 1, 2 and 3:
The dorsal surface of both ears was epidermally treated (25 ¿L/ear) with the test substance concentration, at approximately the same time per day. The concentrations were mixed thoroughly using a vortex mixer immediately prior to dosing. The control animals were treated the same as the experimental animals, except that the vehicle was administered instead of the test substance.

Excision of the nodes - Day 6:
Each animal was injected via the tail vein with 0.25 mL of sterile phosphate buffered saline (PBS; Merck, Darmstadt, Germany) containing 20 ¿Ci of 3H-methyl thymidine (PerkinElmer Life and Analytical Sciences, Boston, MA, US).After approximately five hours, all animals were killed by intraperitoneal injection with Euthasol® 20% (AST Farma BV, Oudewater, The Netherlands). The draining (auricular) lymph node of each ear was excised.
The relative size of the nodes (as compared to normal) was estimated by visual examination and abnormalities of the nodes and surrounding area were recorded. The nodes were pooled for each animal in approximately 3 mL PBS.

Tissue processing for radioactivity - Day 6:
A single cell suspension of lymph node cells (LNC) was prepared in PBS by gentle separation through stainless steel gauze (diameter 125 ¿m). LNC were washed twice with an excess of PBS by centrifugation at 200g for 10 minutes at 4ºC. To precipitate the DNA, the LNC were exposed to 5% trichloroacetic acid (TCA; Merck, Darmstadt, Germany) stored in the refrigerator until the next day.

Radioactivity measurements - Day 7:
Precipitates were recovered by centrifugation, resuspended in 1 mL TCA and transferred to 10 mL of Ultima Gold cocktail (PerkinElmer Life and Analytical Sciences, Boston, MA, US) as the scintillation fluid. Radioactive measurements were performed using a Packard scintillation counter (2800TR). Counting time was to a statistical precision of ± 0.2% or a maximum of 5 minutes whichever came first. The scintillation counter was programmed to automatically subtract background and convert Counts Per Minute (CPM) to Disintegrations Per Minute (DPM).

Observations
Mortality/Viability: Twice daily.
Toxicity: At least once daily.
Body weights: On Days 1 (pre-treatment) and 6.
Necropsy: No necropsy was performed according to protocol.
Irritation: On Day 3 (3-4 hours after treatment), the skin reactions were assessed. Skin reactions were graded according to the following numerical scoring system. Furthermore descriptions of all other (local) effects were recorded.


Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
other: 1-Chloro-2,4-Dinitrobenzene
Statistics:
Not performed.
Positive control results:
The positive control group (1-Chloro-2,4-Dinitrobenzene) added to the study showed that the vehicle is suitable for eliciting an SI>3 in this batch of animals and with the procedures used for this study used.

The six-month reliability check with Alpha-hexylcinnamicaldehyde indicates that the Local Lymph Node Assay as performed at NOTOX is an appropriate model for testing for contact hypersensitivity.
Parameter:
SI
Value:
2.5
Test group / Remarks:
50 %
Parameter:
SI
Value:
1.3
Test group / Remarks:
25 %
Parameter:
SI
Value:
0.7
Test group / Remarks:
10 %

Preliminary iritation study:


Erythema was observed for the animals exposed to 25% and 50%; no systemic toxicity was observed for either animal.


Based on these results, the highest test substance concentration selected for the main study was a 50% concentration.


Main study:


Erythema was observed for all animals at 50% and for one animal at 25%. No oedema was observed for any of the animals treated with CN-NITCAL.


All positive control animals showed erythema and two showed oedema. 


Body weights and body weight gain of experimental animals remained in the same range as controls over the study peiod.


No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study.


 


Mean DPM/animal values for the experimental groups treated with test substance concentrations 10, 25 and 50% were 89, 163 and 313 DPM respectively.The mean DPM/animal value for the vehicle control group was 124 DPM and a mean DPM/animal value of 4497 DPM was obtained from the positive control group.

Interpretation of results:
GHS criteria not met
Conclusions:
The SI values calculated for the substance concentrations 10, 25 and 50% were 0.7, 1.3, and 2.5, respectively.

Since there was no indication that the test substance elicits an SI ¿ 3 when tested up to 50%, CN-NITCAL was considered to be a non skin sensitizer. It was established that the EC3 value (the estimated test substance concentration that will give a SI =3, if any) exceeds 50%.

The positive control group added to the study showed that the vehicle is suitable for eliciting an SI>3 in this batch of animals and with the procedures used for this study used.

The six-month reliability check with Alpha-hexylcinnamicaldehyde indicates that the Local Lymph Node Assay as performed at NOTOX is an appropriate model for testing for contact hypersensitivity.

Based on these results CN-NITCAL would not be regarded as skin sensitizer according to the recommendations made in the test guidelines and does not have to be classified and has no obligatory labeling requirement for sensitization by skin contact according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations (2007) and the Regulation (EC) No 1272/2008 on classification, labeling and packaging of substances and mixtures.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

In a reliable skin sensitisation study, the LLNA test, performed according to OECD 429, EC B42 and EPA guidelines, nitric acid, ammonium calcium salt does not show sensitising properties. The SI values calculated for the substance concentrations 10, 25 and 50% were 0.7, 1.3, and 2.5, respectively. Since there was no indication that the test substance elicits an SI ¿ 3 when tested up to 50%, CN-Nitcal was considered to be a non skin sensitizer. It was established that the EC3 value (the estimated test substance concentration that will give a SI =3, if any) exceeds 50%.

Justification for selection of skin sensitisation endpoint:

One study is available with klimisch code 1.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on the available data, nitric acid, ammonium calcium salt does not have to be classified according to Directive 67/548/EC and the CLP Regulation for skin sensitisation.

Categories Display